Emerging treatments for mesothelioma can be modified versions of existing ones or entirely new therapies altogether. New mesothelioma treatments are currently being studied in clinical trials across the country. Examples of emerging mesothelioma treatments include: Immunotherapy Gene therapy Vaccine therapy Stu...
What Are the New Treatments for Mesothelioma? Experimental new treatment options for mesothelioma include advances such as cancer vaccines, enzyme therapy, gene therapy and virotherapy. These promising treatments may provide hope for patients who don’t respond to standard therapies. Traditional treatments...
New and old treatments for malignant mesothelioma: not just immunotherapydoi:10.1016/S2213-2600(20)30516-6Anna K NowakThe Lancet Respiratory Medicine
Mesothelioma cancer historically has affected men. But now women comprise nearly one-fourth of all cases and incidence rates among women are on the rise.
Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments We reviewed the published literature of clinical studies in malignant mesothelioma (MM), including phase II as well as older single-agent and combination c... A Catalano,W Gianni,A Procopio - 《Critical ...
Treatments that block this pathway are already showing considerable promise in other malignancies, such as melanoma and lung cancer, leading researchers to question whether this same pathway could be active in malignant pleural mesothelioma. "We report that PD-L1 is expressed in 20% of malignant ple...
(5) A "non inferiority" trial of second-line treatment in 571 patients with locally advanced or metastatic non small cell lung cancer showed no significant difference in median survival time with pemetrexed versus docetaxel (about 8 months with both treatments). However, this trial does not rule...
“We are very excited about this discovery and are extremely pleased that it was also chosen to be the featured cover story,” said Yang. “The next step is to translate this discovery into actual treatments formesotheliomapatients.”
The 2015 WHO classification of tumors categorized malignant mesothelioma into epithelioid, biphasic (BMM), and sarcomatoid (SMM) for prognostic relevance a... FG Salle,NL Stang,A Nicholson,... - 《Journal of Thoracic Oncology Official Publication of the International Association for the Study of Lu...
Currently, the first-line test for mesothelioma in patients with a pleural effusion is pleural fluid cytology, but this test is not very sensitive. Dr. Davies and her colleagues undertook the study to determine whether there would be additional clinical benefit to looking at pleural fluid mesotheli...